Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Goldman Sachs Reiterates Sell Rating on Comstock Resources
Goldman Sachs maintains a sell rating on Comstock Resources with a $10 price target.
Wedbush Reiterates Buy Rating on Viridian Therapeutics
Wedbush keeps its buy rating for Viridian Therapeutics, setting a $43 price target.
Barclays Upgrades Watts Water Technologies to 'Buy'
Barclays analyst William Grippin has upgraded Watts Water Technologies to a 'Buy' with a $414 price target.
Raymond James Reiterates Buy Rating for Mid Penn Bancorp
Raymond James continues to support Mid Penn Bancorp with a buy rating and a $38 target.
Barclays Reiterates Buy Rating for Zurn Elkay Water Solutions
Barclays maintains its optimistic outlook on Zurn Elkay with a $59 price target.
Truist Securities Reiterates Buy Rating on Viridian Therapeutics
Truist Securities maintains its buy stance with a $38 target for Viridian Therapeutics.
Barclays Reiterates Sell Rating on Mueller Water Products
Barclays maintains its sell rating on Mueller Water Products with a $25 price target.
Roth Capital Upgrades VersaBank to Buy with $25 Price Target
Roth Capital has upgraded VersaBank to a buy rating, setting a $25 price target.
Litchfield Hills Reiterates Buy Rating on Evolution Metals
Litchfield Hills reaffirmed its buy rating for Evolution Metals with a $12 price target.
Maxim Group Reiterates Buy Rating on AIB Data Centers Inc.
Maxim Group maintains a buy rating for AIB Data Centers Inc. with a $5 price target.
Wells Fargo Reiterates Buy Rating on Zymeworks Inc. (ZYME)
Wells Fargo maintains its buy rating for Zymeworks Inc., setting a price target of $37.
Keybanc Reiterates Buy Rating for Myers Industries
Keybanc maintains its buy rating on Myers Industries with a new price target.
B of A Securities Downgrades Fox Factory Holding Corp. to 'Sell'
B of A Securities lowers its rating on Fox Factory Holding Corp. to 'sell' with a $20 price target.
Wells Fargo Reiterates Buy Rating on Neptune Insurance Holdings
Wells Fargo maintains its buy rating on Neptune Insurance with a price target of $35.
B. Riley Securities Reaffirms Buy Rating on Angel Studios, Inc. (ANGX)
B. Riley Securities maintains its buy rating for Angel Studios with an $8 price target.
RBC Capital Reiterates Buy Rating for Viridian Therapeutics
RBC Capital has maintained its buy rating for Viridian Therapeutics with a $35 price target.
JP Morgan Reiterates Buy Rating on Tenable Holdings, Inc.
JP Morgan has reiterated its buy rating for Tenable Holdings, Inc. with a $40 price target.
DA Davidson Reiterates Buy Rating on Repay Holdings
DA Davidson maintains a Buy rating on Repay Holdings with a $6 price target.
B. Riley Securities Reiterates Buy Rating on Unicycive Therapeutics
B. Riley Securities maintains its buy rating on Unicycive Therapeutics, Inc. with a $22 target price.
Deutsche Bank Reiterates Buy Rating for Owens Corning
Deutsche Bank maintains its buy rating for Owens Corning, setting a new price target of $165.
HC Wainwright Reiterates Buy Rating on Unicycive Therapeutics
HC Wainwright maintains its buy rating on Unicycive Therapeutics with a $15 price target.
UBS Reiterates Buy Rating on Core Natural Resources
UBS maintains its buy rating on Core Natural Resources, setting a $100 target.
Maxim Group Reiterates Buy Rating on Perfect Moment Ltd.
Maxim Group maintains its buy rating on Perfect Moment Ltd. with a $0.40 target.
UBS Reiterates Buy Rating on SSR Mining Inc. (SSRM)
UBS maintains its buy rating for SSR Mining Inc. with a $40 price target.